Anxiety Disorders
📧 Sign up to get email alerts when something new happens for Anxiety Disorders.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-03-25EMA Authorised: Lyrica (pregabalin) — Upjohn EESV
The European Medicines Agency authorised pregabalin (brand Lyrica) for epilepsy, anxiety disorders, and neuralgia, with Upjohn EESV as the m…
-
EMA approval · 2026-02-16EMA Authorised: Pregabalin Zentiva (pregabalin) — Zentiva, k.s.
EMA authorised a generic pregabalin product, Pregabalin Zentiva, for anxiety disorders and epilepsy.
-
EMA approval · 2025-12-19EMA Authorised: Pregabalin Viatris (previously Pregabalin Mylan) (pregabalin) — Viatris Limited
The EMA authorised Pregabalin Viatris for anxiety disorders and epilepsy, with Viatris Limited as the marketing authorisation holder.
-
FDA approval · 2025-12-16FDA Approved: HYDROXYZINE HYDROCHLORIDE — Original Application (ANI Pharmaceuticals, Inc.)
FDA approves ANI Pharmaceuticals' hydroxyzine hydrochloride as a generic product via an Original Application (ANDA 219648), authorizing mark…
-
EMA approval · 2025-12-02EMA Authorised: Pregabalin Sandoz (pregabalin) — Sandoz GmbH
The EMA authorised the Sandoz generic pregabalin product for anxiety disorders, neuralgia, and epilepsy.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-11-14FDA Approved: DIAZEPAM — Original Application (Navinta LLC)
FDA approved Navinta LLC's generic diazepam through an Original Application (ANDA 217468).
-
EMA approval · 2025-11-05EMA Authorised: Pregabalin Viatris Pharma (previously Pregabalin Pfizer) (pregabalin) — Viatris Healthcare Limited
The EMA authorised a pregabalin product under the Viatris Pharma marketing authorisation (formerly Pfizer), for anxiety disorders and epilep…
-
EMA approval · 2025-10-15EMA Authorised: Duloxetine Viatris (previously Duloxetine Mylan) (duloxetine) — Viatris Limited
The European Medicines Agency authorised a duloxetine product marketed as Duloxetine Viatris by Viatris Limited for several indications incl…
-
EMA approval · 2025-08-27EMA Authorised: Pregabalin Accord (pregabalin) — Accord Healthcare S.L.U.
The EMA authorised the generic pregabalin product Pregabalin Accord for anxiety disorders and epilepsy.
-
FDA approval · 2025-03-03FDA Approved: OXAZEPAM — Original Application (Leading Pharma, LLC)
FDA approves Leading Pharma, LLC's Original Application for oxazepam (generic). The approval authorizes the manufacture and marketing of a g…
-
FDA approval · 2024-12-17FDA Approved: DIAZEPAM — Supplemental Application (Lupin Pharmaceuticals,Inc.)
FDA approved a supplemental application for diazepam submitted by Lupin Pharmaceuticals, Inc. The approval relates to changes under the appr…
-
FDA approval · 2024-12-16FDA Approved: DIAZEPAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for diazepam from Hikma Pharmaceuticals USA Inc., updating the approval status of this generic produ…
-
FDA approval · 2024-11-18FDA Approved: LORAZEPAM — Original Application (Fresenius Kabi USA, LLC)
FDA approved the Original Application for lorazepam from Fresenius Kabi USA, LLC, granting a generic version of the drug.
-
FDA approval · 2024-07-18FDA Approved: DIAZEPAM — Original Application (Dr. Reddy's Laboratories Inc)
FDA approves the Diazepam original application for Dr. Reddy's Laboratories Inc, establishing a generic Diazepam product in the U.S. underAN…
-
EMA approval · 2024-07-09EMA Authorised: Cymbalta (duloxetine) — Eli Lilly Nederland B.V.
Cymbalta (duloxetine) has been authorized by the EMA for anxiety disorders, diabetic neuropathy, and major depressive disorder with Eli Lill…
-
FDA approval · 2024-07-01FDA Approved: DOXEPIN — Original Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA Inc.'s original application for doxepin (Doxepin), a generic antidepressant/tricyclic used for depression, an…
-
FDA approval · 2024-06-07FDA Approved: LORAZEPAM — Supplemental Application (International Medication Systems, Limited)
FDA approved a supplemental application for lorazepam from International Medication Systems, Limited (ANDA 076150).
-
FDA approval · 2024-04-25FDA Approved: DIAZEPAM — Original Application (Alembic Pharmaceuticals Limited)
FDA approves Alembic Pharmaceuticals Limited's original application for a generic diazepam product. This approval supports a generic version…
-
FDA approval · 2024-02-12FDA Approved: LORAZEPAM — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for lorazepam from Amneal Pharmaceuticals LLC.
-
FDA approval · 2023-11-22FDA Approved: DIAZEPAM — Supplemental Application (Sunrise Pharmaceutical, Inc.)
The FDA approved a supplemental application for Diazepam submitted by Sunrise Pharmaceutical, Inc.
-
FDA approval · 2023-10-11FDA Approved: VALIUM — Supplemental Application (Roche Laboratories Inc.)
FDA approved a Supplemental Application for Valium (diazepam) from Roche Laboratories Inc., indicating an approved change or addition to the…
-
FDA approval · 2023-09-25FDA Approved: LORAZEPAM — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for lorazepam submitted by Hospira, Inc. under ANDA 074243.
-
FDA approval · 2023-09-14FDA Approved: CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE — Original Application (Aurobindo Pharma Limited)
FDA approved a generic formulation of chlordiazepoxide hydrochloride and clidinium bromide from Aurobindo Pharma Limited under an Original A…
-
FDA approval · 2023-08-16FDA Approved: DOXEPIN HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals NY LLC)
The FDA approved the original application for a generic doxepin hydrochloride product from Amneal Pharmaceuticals NY LLC. The generic is ind…
-
FDA approval · 2023-07-10FDA Approved: DIAZEPAM — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for Diazepam from Oceanside Pharmaceuticals.